O	0	8	Research	Research	NN	B-NP
O	9	17	advances	advance	NNS	I-NP
O	18	20	of	of	IN	B-PP
O	21	31	endostatin	endostatin	NN	B-NP
O	32	35	and	and	CC	O
O	36	39	its	its	PRP$	B-NP
O	40	45	short	short	JJ	I-NP
O	46	54	internal	internal	JJ	I-NP
O	55	64	fragments	fragment	NNS	I-NP
O	64	65	.	.	.	O

O	66	76	Endostatin	Endostatin	NN	B-NP
O	76	77	,	,	,	O
O	78	81	the	the	DT	B-NP
O	82	83	C	C	NN	I-NP
O	83	84	-	-	HYPH	B-NP
O	84	92	terminal	terminal	JJ	I-NP
O	93	101	fragment	fragment	NN	I-NP
O	102	104	of	of	IN	B-PP
O	105	113	collagen	collagen	NN	B-NP
O	114	119	XVIII	XVIII	NN	I-NP
O	119	120	,	,	,	O
O	121	123	is	be	VBZ	B-VP
O	124	125	a	a	DT	B-NP
O	126	132	potent	potent	JJ	I-NP
O	133	145	angiogenesis	angiogenesis	NN	I-NP
O	146	155	inhibitor	inhibitor	NN	I-NP
O	155	156	.	.	.	O

O	157	159	At	At	IN	B-PP
O	160	167	present	present	NN	B-NP
O	167	168	,	,	,	O
O	169	174	there	there	EX	B-NP
O	175	178	are	be	VBP	B-VP
O	179	180	a	a	DT	B-NP
O	181	186	large	large	JJ	I-NP
O	187	193	number	number	NN	I-NP
O	194	196	of	of	IN	B-PP
O	197	205	research	research	NN	B-NP
O	206	212	papers	paper	NNS	I-NP
O	213	215	on	on	IN	B-PP
O	216	226	endostatin	endostatin	NN	B-NP
O	226	227	.	.	.	O

O	228	235	However	However	RB	B-ADVP
O	235	236	,	,	,	O
O	237	240	the	the	DT	B-NP
O	241	247	action	action	NN	I-NP
O	248	257	mechanism	mechanism	NN	I-NP
O	258	260	of	of	IN	B-PP
O	261	271	endostatin	endostatin	NN	B-NP
O	272	274	is	be	VBZ	B-VP
O	275	280	still	still	RB	B-ADVP
O	281	282	a	a	DT	B-NP
O	283	289	matter	matter	NN	I-NP
O	290	292	of	of	IN	B-PP
O	293	300	ongoing	ongoing	JJ	B-NP
O	301	311	discussion	discussion	NN	I-NP
O	311	312	.	.	.	O

O	313	316	The	The	DT	B-NP
O	317	326	objective	objective	NN	I-NP
O	327	329	of	of	IN	B-PP
O	330	334	this	this	DT	B-NP
O	335	341	review	review	NN	I-NP
O	342	344	is	be	VBZ	B-VP
O	345	347	to	to	TO	B-VP
O	348	357	elucidate	elucidate	VB	I-VP
O	358	361	its	its	PRP$	B-NP
O	362	368	origin	origin	NN	I-NP
O	369	372	and	and	CC	I-NP
O	373	383	elementary	elementary	JJ	I-NP
O	384	393	structure	structure	NN	I-NP
O	393	394	,	,	,	O
O	395	398	and	and	CC	O
O	399	401	to	to	TO	B-VP
O	402	409	discuss	discuss	VB	I-VP
O	410	413	its	its	PRP$	B-NP
O	414	423	structure	structure	NN	I-NP
O	424	429	basis	basis	NN	I-NP
O	430	432	of	of	IN	B-PP
O	433	441	activity	activity	NN	B-NP
O	442	445	and	and	CC	I-NP
O	446	452	action	action	NN	I-NP
O	453	463	mechanisms	mechanism	NNS	I-NP
O	464	469	based	base	VBN	B-VP
O	470	472	on	on	IN	B-PP
O	473	476	the	the	DT	B-NP
O	477	483	latest	late	JJS	I-NP
O	484	492	research	research	NN	I-NP
O	492	493	.	.	.	O

O	494	505	Furthermore	Furthermore	RB	B-ADVP
O	505	506	,	,	,	O
O	507	511	some	some	DT	B-NP
O	512	521	published	publish	VBN	I-NP
O	522	529	studies	study	NNS	I-NP
O	530	539	reporting	report	VBG	B-VP
O	540	543	the	the	DT	B-NP
O	544	558	antiangiogenic	antiangiogenic	JJ	I-NP
O	559	566	effects	effect	NNS	I-NP
O	567	569	of	of	IN	B-PP
O	570	580	endostatin	endostatin	NN	B-NP
O	580	581	-	-	HYPH	B-NP
O	581	588	derived	derive	VBN	I-NP
O	589	597	peptides	peptide	NNS	I-NP
O	598	602	were	be	VBD	B-VP
O	603	607	also	also	RB	I-VP
O	608	616	reviewed	review	VBN	I-VP
O	616	617	.	.	.	O

O	618	620	It	It	PRP	B-NP
O	621	623	is	be	VBZ	B-VP
O	624	632	proposed	propose	VBN	I-VP
O	633	637	that	that	IN	B-SBAR
O	638	641	the	the	DT	B-NP
O	642	647	amino	amino	JJ	I-NP
O	648	652	acid	acid	NN	I-NP
O	653	661	sequence	sequence	NN	I-NP
O	662	664	of	of	IN	B-PP
O	665	675	endostatin	endostatin	NN	B-NP
O	676	684	contains	contain	VBZ	B-VP
O	685	689	both	both	CC	O
O	690	706	angiosuppressive	angiosuppressive	JJ	B-NP
O	707	710	and	and	CC	I-NP
O	711	727	angiostimulatory	angiostimulatory	JJ	I-NP
O	728	735	domains	domain	NNS	I-NP
O	735	736	.	.	.	O

O	737	742	Short	Short	JJ	B-NP
O	743	753	endostatin	endostatin	NN	I-NP
O	754	763	fragments	fragment	NNS	I-NP
O	764	767	may	may	MD	B-VP
O	768	770	be	be	VB	I-VP
O	771	780	exploited	exploit	VBN	I-VP
O	781	783	as	as	IN	B-PP
O	784	785	a	a	DT	B-NP
O	786	789	new	new	JJ	I-NP
O	790	802	angiogenesis	angiogenesis	NN	I-NP
O	803	812	inhibitor	inhibitor	NN	I-NP
O	813	816	for	for	IN	B-PP
O	817	828	therapeutic	therapeutic	JJ	B-NP
O	829	841	applications	application	NNS	I-NP
O	841	842	,	,	,	O
O	843	845	in	in	IN	B-PP
O	846	858	substitution	substitution	NN	B-NP
O	859	861	of	of	IN	B-PP
O	862	865	the	the	DT	B-NP
O	866	870	full	full	JJ	I-NP
O	871	877	length	length	NN	I-NP
O	878	888	endostatin	endostatin	NN	I-NP
O	888	889	.	.	.	O

O	890	895	These	These	DT	B-NP
O	896	903	studies	study	NNS	I-NP
O	904	906	on	on	IN	B-PP
O	907	917	endostatin	endostatin	NN	B-NP
O	918	927	fragments	fragment	NNS	I-NP
O	928	932	also	also	RB	B-ADVP
O	933	937	shed	shed	VBD	B-VP
O	938	943	light	light	NN	B-NP
O	944	946	on	on	IN	B-PP
O	947	950	our	our	PRP$	B-NP
O	951	964	understanding	understanding	NN	I-NP
O	965	967	of	of	IN	B-PP
O	968	971	the	the	DT	B-NP
O	972	981	molecular	molecular	JJ	I-NP
O	982	988	action	action	NN	I-NP
O	989	999	mechanisms	mechanism	NNS	I-NP
O	1000	1002	of	of	IN	B-PP
O	1003	1013	endostatin	endostatin	NN	B-NP
O	1013	1014	.	.	.	O

